Designer drugs pose significant challenges to toxicologists due to their rapid evolution and the difficulty in detecting them with standard drug tests. Their novel structures may not be recognized by existing detection methodologies, necessitating continuous development of new analytical techniques. Moreover, they often come with unknown adverse effects, complicating medical responses to overdoses and poisoning.
